New Insight into Benign Tumours of Major Salivary Glands by Proteomic Approach

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Donadio, Elena ^a   Giusti, Laura ^a   Seccia, Veronica ^b   Ciregia, Federica ^a   da Valle, Ylenia ^a   Dallan, Iacopo ^b   Ventroni, Tiziana ^a   Giannaccini, Gino ^a   Sellari Franceschini, Stefano ^b   Lucacchini, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CRYSTALLINE B CHAIN; APOLIPOPROTEIN E; CALGRANULIN B; CELL PROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN ALPHA 1 CHAIN C; IMMUNOGLOBULIN GAMMA 1 CHAIN C; IMMUNOGLOBULIN KAPPA CHAIN C; LIPOCORTIN 1; LIPOCORTIN 4; MACROPHAGE CAPPING PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DEATH; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER PROGRAM; DIAGNOSTIC ACCURACY; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; HUMAN TISSUE; MALE; MASS SPECTROMETRY; PAROTIDECTOMY; PLEOMORPHIC ADENOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION; WARTHIN TUMOR; WESTERN BLOTTING;

ADENOLYMPHOMA; ADENOMA, PLEOMORPHIC; BLOTTING, WESTERN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MASS SPECTROMETRY; PROTEOME; PROTEOMICS; SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS; UP-REGULATION;

EID: 84883183091     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071874     Document Type: Article

References (37)

1. Eveson JW, Cawson RA, (1985) Tumours of the minor (oropharyngeal) salivary glands: a demographic study of 336 cases. J Oral Pathol 14: 500-509.
2. Heller KS, Dubner S, Chess Q, Attie JN, (1992) Value of fine needle aspiration biopsy of salivary gland masses in clinical decision-making. Am J Surg 164: 667-670.
3. Fakhry N, Antonini F, Michel J, Penicaud M, Mancini J, et al. (2012) Fine-needle aspiration cytology in the management of parotid masses: evaluation of 249 patients. Eur Ann Otorhinolaryngol Head Neck Dis 129: 131-135.
4. Tryggvason G, Gailey MP, Hulstein SL, Karnell LH, Hoffman HT, et al. (2013) Accuracy of fine-needle aspiration and imaging in the preoperative workup of salivary gland mass lesions treated surgically. Laryngoscope 123: 158-163.
5. Nagel H, Hotze HJ, Laskawi R, Chilla R, Droese M, (1999) Cytologic diagnosis of adenoid cystic carcinoma of salivary glands. Diagn Cytopathol 20: 358-366.
6. Stewart CJ, MacKenzie K, McGarry GW, Mowat A, (2000) Fine-needle aspiration cytology of salivary gland: a review of 341 cases. Diagn Cytopathol 22: 139-146.
7. Yaranal PJ, Umashankar T, (2013) Squamous Cell Carcinoma Arising in Warthin's Tumour: A Case Report. J Clin Diagn Res 7: 163-165.
8. Viguer JM, Vicandi B, Jiménez-Heffernan JA, López-Ferrer P, González-Peramato P, et al. (2010) Role of fine needle aspiration cytology in the diagnosis and management of Warthin's tumour of the salivary glands. Cytopathology. 21: 164-169.
9. Tripathi SC, Matta A, Kaur J, Grigull J, Chauhan SS, et al. (2010) Nuclear S100A7 is associated with poor prognosis in head and neck cancer. PLoS One 5: e11939.
10. Tripathi SC, Matta A, Kaur J, Grigull J, Chauhan SS, et al. (2011) Overexpression of prothymosin alpha predicts poor disease outcome in head and neck cancer. PLoS One 6: e19213.
11. Ralhan R, Masui O, Desouza LV, Matta A, Macha M, et al. (2011) Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: Strategy for discovery of candidate serological biomarkers. Proteomics 11: 2363-2376.
12. Gonzalez-Begne M, Lu B, Han X, Hagen FK, Hand AR, et al. (2009) Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). J Proteome Res 8: 1304-1314.
13. Giusti L, Iacconi P, Ciregia F, Giannaccini G, Basolo F, et al. (2007) Proteomic analysis of human thyroid fine needle aspiration fluid. J Endocrinol Invest 30: 865-869.
14. Giusti L, Iacconi P, Ciregia F, Giannaccini G, Donatini GL, et al. (2008) Fine-needle aspiration of thyroid nodules: proteomic analysis to identify cancer biomarkers. J Proteome Res 7: 4079-4088.
15. Eveson JW, Auclair P, Gnepp DR (2005) Tumors of the salivary glands. Barnes L, Eveson J, Reichart P, Sidransky D (Eds.), Pathology and Genetics of Head and Neck Tumors. World Health Organization Classification of Tumors, IARC Press, Lyon, 209-281.
16. Giusti L, Cetani F, Ciregia F, Da Valle Y, Donadio E, et al. (2011) A proteomic approach to study parathyroid glands. Mol Biosyst 7: 687-699.
17. Aude-Garcia C, Collin-Faure V, Luche S, Rabilloud T, (2011) Improvements and simplifications in in-gel fluorescent detection of proteins using ruthenium II tris-(bathophenanthroline disulfonate): the poor man's fluorescent detection method. Proteomics 11: 324-328.
18. Soggiu A, Piras C, Bonizzi L, Hussein HA, Pisanu S, et al. (2012) A discovery-phase urine proteomics investigation in type 1 diabetes. Acta Diabetol 49: 453-464.
19. Teymoortash A, Werner JA, Moll R, (2011) Is Warthin's tumour of the parotid gland a lymph node disease? Histopathology 59: 143-145.
20. Giusti L, Baldini C, Ciregia F, Giannaccini G, Giacomelli C, et al. (2010) Is GRP78/BiP a potential salivary biomarker in patients with rheumatoid arthritis? Proteomics Clin Appl 4: 315-324.
21. Giusti L, Baldini C, Bazzichi L, Ciregia F, Tonazzini I, et al. (2007) Proteome analysis of whole saliva: a new tool for rheumatic diseases--the example of Sjögren's syndrome. Proteomics 7: 1634-1643.
22. Giusti L, Bazzichi L, Baldini C, Ciregia F, Mascia G, et al. (2007) Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis. J Rheumatol 34: 2063-2069.
23. Baldini C, Giusti L, Ciregia F, Da Valle Y, Giacomelli C, et al. (2011) Correspondence between salivary proteomic pattern and clinical course in primary Sjögren syndrome and non-Hodgkin's lymphoma: a case report. J Transl Med 9: 188.
24. Dǎguci L, Simionescu C, Stepan A, Munteanu C, Dǎguci C, et al. (2011) Warthin tumor-morphological study of the stromal compartment. Rom J Morphol Embryol 52: 1319-1323.
25. Casella JF, Maack DJ, Lin S, (1986) Purification and initial characterization of a protein from skeletal muscle that caps the barbed ends of actin filaments. J Biol Chem 261: 10915-10921.
26. Ha ES, Choi S, In KH, Lee SH, Lee EJ, et al. (2013) Identification of proteins expressed differently among surgically resected stage I lung adenocarcinomas. Clin Biochem 46: 369-377.
27. Morofuji N, Ojima H, Onaya H, Okusaka T, Shimada K, et al. (2012) Macrophage-capping protein as a tissue biomarker for prediction of response to gemcitabine treatment and prognosis in cholangiocarcinoma. J Proteomics 75: 1577-1589.
28. Wu JH, Tian XY, Hao CY, (2011) The significance of a group of molecular markers and clinicopathological factors in identifying colorectal liver metastasis. Hepatogastroenterology 58: 1182-1188.
29. Renz M, Betz B, Niederacher D, Bender HG, Langowski J, (2008) Invasive breast cancer cells exhibit increased mobility of the actin binding protein CapG. Int J Cancer 122: 1476-1482.
30. Partheen K, Levan K, Osterberg L, Claesson I, Fallenius G, et al. (2008) Four potential biomarkers as prognostic factors in stage III serous ovarian adenocarcinomas. Int J Cancer 23: 2130-2137.
31. Nomura H, Uzawa K, Ishigami T, Kouzu Y, Koike H, et al. (2008) Clinical significance of gelsolin-like actin-capping protein expression in oral carcinogenesis: an immunohistochemical study of premalignant and malignant lesions of the oral cavity. BMC Cancer 8: 39.
32. Thompson CC, Ashcroft FJ, Patel S, Saraga G, Vimalachandran D, et al. (2007) Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility. Gut 56: 95-106.
33. Li MX, Xiao ZQ, Chen YH, Peng F, Li C, et al. (2010) Proteomic analysis of the stroma-related proteins in nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissues. Med Oncol 27: 134-144.
34. Kimura K, Ojima H, Kubota D, Sakumoto M, Nakamura Y, et al. (2013) Proteomic identification of the macrophage-capping protein as a protein contributing to the malignant features of hepatocellular carcinoma. J Proteomics 78: 362-373.
35. Volkmann J, Reuning U, Rudelius M, Häfner N, Schuster T, et al. (2012) High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells. Int J Cancer doi: 10.1002/ijc.27975.
36. Mussunoor S, Murray GI, (2008) The role of annexins in tumour development and progression. J Pathol 216: 131-140.
37. Giusti L, Cetani F, Ciregia F, Da Valle Y, Donadio E, et al. (2011) A proteomic approach to study parathyroid glands. Mol Biosyst 7: 687-699.